CHANGE HEALTHCARE INC (CHNG)       27.49  +0.07 (+0.26%)

27.49  +0.07 (+0.26%)

US15912K1007 - Common Stock - After market: 27.45 -0.04 (-0.15%)


Fundamental Rating

4

Taking everything into account, CHNG scores 4 out of 10 in our fundamental rating. CHNG was compared to 49 industry peers in the Health Care Technology industry. CHNG has a medium profitability rating, but doesn't score so well on its financial health evaluation. While showing a medium growth rate, CHNG is valued expensive at the moment.




Profitability

Profitability Rating

4

CHNG's Return On Assets of -0.80% is amongst the best of the industry. CHNG does better than the industry average Return On Assets of -23.07%.
CHNG's Profit Margin of -2.20% is amongst the best of the industry. CHNG does better than the industry average Profit Margin of -49.01%.

CHNG has a Piotroski-F score of 6.00. This indicates an average health and profitability for CHNG.
CHNG has negative profitability rations, so we won't be analyzing them here.
VS Industry

ROA (-0.8%) VS Industry: 71% outperformed.

-287.25
55.48

Profit Margin (-2.2%) VS Industry: 72% outperformed.

-8,210.80
36.70

Valuation

Valuation Rating

3

Compared to an average industry Price/Earning Ratio of 44.96, CHNG is valued a bit cheaper than its industry peers.
The Price/Earnings Ratio is 18.57, which indicates a rather expensive current valuation of CHNG.
The Forward Price/Earnings Ratio of 15.89 indicates a correct valuation of CHNG.

With a price book ratio of 2.74, CHNG is valued correctly.
Compared to an average industry Enterprise Value to EBITDA ratio of 19.83, CHNG is valued in line with its industry peers.
Compared to an average industry price book ratio of 2.37, CHNG is valued more expensive than its industry peers.
VS Industry

Price/Earnings (18.57) VS Industry: 76% outperformed.

114.50
9.81

Price/Book (2.74) VS Industry: 37% outperformed.

18.96
0.17

Enterprise Value/ EBITDA (16.58) VS Industry: 52% outperformed.

57.63
0.53

Growth

Growth Rating

5

Based on estimates for the next 5 years, CHNG will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.03% on average per year.
When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
CHNG shows a strong growth in Revenue. Measured over the last 5 years, the Revenue has been growing by 62.25% yearly.
The earnings per share for CHNG have decreased by -0.67% in the last year.

CHNG shows a decrease in Earnings Per Share. Measured over the last 5 years, the EPS has been decreasing by -2.24% yearly.
The Revenue has been growing slightly by 7.15% in the past year.
The Revenue is expected to grow by 4.23% on average over the next 5 years.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A -2.24% -0.67% -1.57% 7.05% 10% 12.03%
Revenue62.25% 1.98% 7.15% 3.51% 3.6% 4.45% 4.23%

Health

Health Rating

3

CHNG has a Current Ratio of 1.23. This is a normal value and indicates that CHNG is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 1.23 indicates that CHNG should not have too much problems paying its short term obligations.
CHNG has a Altman-Z score comparable to the industry average, which is at 1.01.
CHNG has a Piotroski-F score of 6.00. This indicates an average health and profitability for CHNG.

Compared to an average industry Current Ratio of 2.30, CHNG is worse placed to pay its short term obligations than its industry peers.
Compared to an average industry Quick Ratio of 2.30, CHNG is worse placed to pay its short term obligations than its industry peers.
Compared to an average industry Debt to Equity Ratio of 0.12, CHNG is requires more financing than its industry peers. 88% of its industry peers have a better Debt to Equity Ratio.
Based on the Altman-Z score of 1.12, we must say that CHNG is in the distress zone and has some risk of bankruptcy.
VS Industry

Debt/Equity (1.36) VS Industry: 12% outperformed.

4.07
0.00

Quick Ratio (1.23) VS Industry: 26% outperformed.

0.09
18.98

Current Ratio (1.23) VS Industry: 23% outperformed.

0.09
18.98

Altman-Z (1.12) VS Industry: 52% outperformed.

-88.40
131.99

Dividend

Dividend Rating

0

No dividends for CHNG!.

CHNG Daily chart

CHANGE HEALTHCARE INC27.49

NASDAQ:CHNG (9/30/2022, 7:12:24 PM)+0.07 (+0.26%)

After market: 27.45 -0.04 (-0.15%)

Chartmill FA Rating
GICS Sector Health Care
GICS IndustryGroup Health Care Equipment & Services
GICS Industry Health Care Technology
Earnings (Last) 08-03 2022-08-03/amc Earnings (Next) 11-02 2022-11-02/amc
Ins Owners 0.04% Inst Owners 99.75%
Market Cap 9.03B Analysts 71.76
Valuation
PE 18.57 Fwd PE 15.89
PEG (NY) N/A PEG (5Y) N/A
P/S 2.58 P/B 2.74
EV/EBITDA 16.58
Dividend
Dividend Yield N/A Dividend Growth N/A
DP N/A Ex-Date N/A
Growth
EPS 1Y -0.67% EPS 3Y -2.24%
EPS 5Y N/A EPS growth Q2Q -7.32%
EPS Next Y -1.57% EPS Next 2Y 7.05%
EPS Next 3Y 10% EPS Next 5Y 12.03%
Revenue growth 1Y 7.15% Revenue growth 3Y 1.98%
Revenue growth 5Y 62.25% Revenue growth Q2Q 1.91%
Revenue Next Year 3.51% Revenue Next 2Y 3.6%
Revenue Next 3Y 4.45% Revenue Next 5Y 4.23%
Health
Current Ratio 1.23 Quick Ratio 1.23
Altman-Z 1.12 F-Score 6
Debt/Equity 1.36 WACC 9.35%
ROIC/WACC 1
Profitability
ROA -0.8% ROE N/A
ROICexgc 9.33% ROIC 1.09%
PM -2.2% OM 3.43%
Asset Turnover 0.36

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA